טוען...
Protein deimmunization via structure-based design enables efficient epitope deletion at high mutational loads
Anti-drug immune responses are a unique risk factor for biotherapeutics, and undesired immunogenicity can alter pharmacokinetics, compromise drug efficacy, and in some cases even threaten patient safety. To fully capitalize on the promise of biotherapeutics, more efficient and generally applicable p...
שמור ב:
| הוצא לאור ב: | Biotechnol Bioeng |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4452428/ https://ncbi.nlm.nih.gov/pubmed/25655032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bit.25554 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|